China DPP IV Inhibitor Market Research Report Forecast 2017-2021

June 2017 | 109 pages | ID: CE29D59E9A9EN
S&P Consulting

Abstracts

The China DPP IV Inhibitor Market Research Report Forecast 2017-2021 is a valuable source of insightful data for business strategists. It provides the DPP IV Inhibitor industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This DPP IV Inhibitor market study provides comprehensive data which enhances the understanding, scope and application of this report.

This report provides comprehensive analysis of

• Key market segments and sub-segments
• Evolving market trends and dynamics
• Changing supply and demand scenarios
• Quantifying market opportunities through market sizing and market forecasting
• Tracking current trends/opportunities/challenges
• Competitive insights
• Opportunity mapping in terms of technological breakthroughs

The Major players reported in the market include:
AstraZeneca Plc. (UK)
Boehringer Ingelheim GmbH (Germany)
Eli Lilly and Company (US)
Merck & Co, Inc. (US)
Mitsubishi Tanabe Pharma Corporation (Japan)
Novartis AG (Switzerland)
Takeda Pharmaceutical Company Limited (Japan)
company 8
company 9

China DPP IV Inhibitor Market: Product Segment Analysis
Type 1
Type 2
Type 3

China DPP IV Inhibitor Market: Application Segment Analysis
Application 1
Application 2
Application 3

Reasons for Buying this Report

• This report provides pin-point analysis for changing competitive dynamics
• It provides a forward looking perspective on different factors driving or restraining market growth
• It provides a six-year forecast assessed on the basis of how the market is predicted to grow
• It helps in understanding the key product segments and their future
• It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
• It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

Contents

CHAPTER 1 DPP IV INHIBITOR MARKET OVERVIEW

1.1 Product Overview and Scope of DPP IV Inhibitor
1.2 DPP IV Inhibitor Market Segmentation by Type
  1.2.1 China Production Market Share of DPP IV Inhibitor by Type 1n 2016
  1.2.1 Type
  1.2.2 Type
  1.2.3 Type
1.3 DPP IV Inhibitor Market Segmentation by Application
  1.3.1 DPP IV Inhibitor Consumption Market Share by Application in 2016
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 China Market Size Sales (Value) and Revenue (Volume) of DPP IV Inhibitor (2012-2021)

CHAPTER 2 CHINA ECONOMIC IMPACT ON DPP IV INHIBITOR INDUSTRY

2.1 China Macroeconomic Environment Analysis
  2.1.1 China Macroeconomic Analysis
  2.1.2 China Macroeconomic Environment Development Trend
2.2 Effects to DPP IV Inhibitor Industry

CHAPTER 3 CHINA DPP IV INHIBITOR MARKET COMPETITION BY MANUFACTURERS

3.1 China DPP IV Inhibitor Production and Share by Manufacturers (2015 and 2016)
3.2 China DPP IV Inhibitor Revenue and Share by Manufacturers (2015 and 2016)
3.3 China DPP IV Inhibitor Average Price by Manufacturers (2015 and 2016)
3.4 Manufacturers DPP IV Inhibitor Manufacturing Base Distribution, Production Area and Product Type
3.5 DPP IV Inhibitor Market Competitive Situation and Trends
  3.5.1 DPP IV Inhibitor Market Concentration Rate
  3.5.2 DPP IV Inhibitor Market Share of Top 3 and Top 5 Manufacturers
  3.5.3 Mergers & Acquisitions, Expansion

CHAPTER 4 CHINA DPP IV INHIBITOR CAPACITY, PRODUCTION, REVENUE, CONSUMPTION, EXPORT AND IMPORT (2012-2017)

4.1 China DPP IV Inhibitor Capacity, Production and Growth (2012-2017)
4.2 China DPP IV Inhibitor Revenue and Growth (2012-2017)
4.3 China DPP IV Inhibitor Production, Consumption, Export and Import (2012-2017)

CHAPTER 5 CHINA DPP IV INHIBITOR PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

5.1 China DPP IV Inhibitor Production and Market Share by Type (2012-2017)
5.2 China DPP IV Inhibitor Revenue and Market Share by Type (2012-2017)
5.3 China DPP IV Inhibitor Price by Type (2012-2017)
5.4 China DPP IV Inhibitor Production Growth by Type (2012-2017)

CHAPTER 6 CHINA DPP IV INHIBITOR MARKET ANALYSIS BY APPLICATION

6.1 China DPP IV Inhibitor Consumption and Market Share by Application (2012-2017)
6.2 China DPP IV Inhibitor Consumption Growth Rate by Application (2012-2017)
6.3 Market Drivers and Opportunities
  6.3.1 Potential Applications
  6.3.2 Emerging Markets/Countries

CHAPTER 7 CHINA DPP IV INHIBITOR MANUFACTURERS ANALYSIS

7.1 AstraZeneca Plc. (UK)
  7.1.1 Company Basic Information, Manufacturing Base and Competitors
  7.1.2 Product Type, Application and Specification
  7.1.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.1.4 Business Overview
7.2 Boehringer Ingelheim GmbH (Germany)
  7.2.1 Company Basic Information, Manufacturing Base and Competitors
  7.2.2 Product Type, Application and Specification
  7.2.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.2.4 Business Overview
7.3 Eli Lilly and Company (US)
  7.3.1 Company Basic Information, Manufacturing Base and Competitors
  7.3.2 Product Type, Application and Specification
  7.3.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.3.4 Business Overview
7.4 Merck & Co, Inc. (US)
  7.4.1 Company Basic Information, Manufacturing Base and Competitors
  7.4.2 Product Type, Application and Specification
  7.4.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.4.4 Business Overview
7.5 Mitsubishi Tanabe Pharma Corporation (Japan)
  7.5.1 Company Basic Information, Manufacturing Base and Competitors
  7.5.2 Product Type, Application and Specification
  7.5.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.5.4 Business Overview
7.6 Novartis AG (Switzerland)
  7.6.1 Company Basic Information, Manufacturing Base and Competitors
  7.6.2 Product Type, Application and Specification
  7.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.6.4 Business Overview
7.7 Takeda Pharmaceutical Company Limited (Japan)
  7.7.1 Company Basic Information, Manufacturing Base and Competitors
  7.7.2 Product Type, Application and Specification
  7.7.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.7.4 Business Overview
7.8 company
  7.8.1 Company Basic Information, Manufacturing Base and Competitors
  7.8.2 Product Type, Application and Specification
  7.8.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.8.4 Business Overview
7.9 company
  7.9.1 Company Basic Information, Manufacturing Base and Competitors
  7.9.2 Product Type, Application and Specification
  7.9.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.9.4 Business Overview

CHAPTER 8 DPP IV INHIBITOR MANUFACTURING COST ANALYSIS

8.1 DPP IV Inhibitor Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of DPP IV Inhibitor

CHAPTER 9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

9.1 DPP IV Inhibitor Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of DPP IV Inhibitor Major Manufacturers in 2015
9.4 Downstream Buyers

CHAPTER 10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

CHAPTER 11 MARKET EFFECT FACTORS ANALYSIS

11.1 Technology Progress/Risk
  11.1.1 Substitutes Threat
  11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

CHAPTER 12 CHINA DPP IV INHIBITOR MARKET FORECAST (2017-2021)

12.1 China DPP IV Inhibitor Production, Revenue Forecast (2017-2021)
12.2 China DPP IV Inhibitor Production, Consumption Forecast by Regions (2017-2021)
12.3 China DPP IV Inhibitor Production Forecast by Type (2017-2021)
12.4 China DPP IV Inhibitor Consumption Forecast by Application (2017-2021)
12.5 DPP IV Inhibitor Price Forecast (2017-2021)

CHAPTER 13 APPENDIX

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of DPP IV Inhibitor
Figure China Production Market Share of DPP IV Inhibitor by Type 1n 2016
Table DPP IV Inhibitor Consumption Market Share by Application in 2016
Figure China DPP IV Inhibitor Revenue (Million USD) and Growth Rate (2012-2021)
Table China DPP IV Inhibitor Capacity of Key Manufacturers (2015 and 2016)
Table China DPP IV Inhibitor Capacity Market Share of Key Manufacturers (2015 and 2016)
Figure China DPP IV Inhibitor Capacity of Key Manufacturers in 2015
Figure China DPP IV Inhibitor Capacity of Key Manufacturers in 2016
Table China DPP IV Inhibitor Production of Key Manufacturers (2015 and 2016)
Table China DPP IV Inhibitor Production Share by Manufacturers (2015 and 2016)
Figure 2015 DPP IV Inhibitor Production Share by Manufacturers
Figure 2016 DPP IV Inhibitor Production Share by Manufacturers
Table China DPP IV Inhibitor Revenue (Million USD) by Manufacturers (2015 and 2016)
Table China DPP IV Inhibitor Revenue Share by Manufacturers (2015 and 2016)
Table 2015 China DPP IV Inhibitor Revenue Share by Manufacturers
Table 2016 China DPP IV Inhibitor Revenue Share by Manufacturers
Table China Market DPP IV Inhibitor Average Price of Key Manufacturers (2015 and 2016)
Figure China Market DPP IV Inhibitor Average Price of Key Manufacturers in 2015
Table Manufacturers DPP IV Inhibitor Manufacturing Base Distribution and Sales Area
Table Manufacturers DPP IV Inhibitor Product Type
Figure DPP IV Inhibitor Market Share of Top 3 Manufacturers
Figure DPP IV Inhibitor Market Share of Top 5 Manufacturers
Table Church & Dwight Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Church & Dwight DPP IV Inhibitor Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Church & Dwight DPP IV Inhibitor Market Share (2012-2017)
Table AstraZeneca Plc. (UK) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table AstraZeneca Plc. (UK) DPP IV Inhibitor Production, Revenue, Price and Gross Margin (2012-2017)
Table AstraZeneca Plc. (UK) DPP IV Inhibitor Market Share (2012-2017)
Table Boehringer Ingelheim GmbH (Germany) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Boehringer Ingelheim GmbH (Germany) DPP IV Inhibitor Production, Revenue, Price and Gross Margin (2012-2017)
Table Boehringer Ingelheim GmbH (Germany) DPP IV Inhibitor Market Share (2012-2017)
Table Eli Lilly and Company (US) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Eli Lilly and Company (US) DPP IV Inhibitor Production, Revenue, Price and Gross Margin (2012-2017)
Table Eli Lilly and Company (US) DPP IV Inhibitor Market Share (2012-2017)
Table Merck & Co, Inc. (US) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Merck & Co, Inc. (US) DPP IV Inhibitor Production, Revenue, Price and Gross Margin (2012-2017)
Table Merck & Co, Inc. (US) DPP IV Inhibitor Market Share (2012-2017)
Table Mitsubishi Tanabe Pharma Corporation (Japan) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Mitsubishi Tanabe Pharma Corporation (Japan) DPP IV Inhibitor Production, Revenue, Price and Gross Margin (2012-2017)
Table Mitsubishi Tanabe Pharma Corporation (Japan) DPP IV Inhibitor Market Share (2012-2017)
Table Novartis AG (Switzerland) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Novartis AG (Switzerland) DPP IV Inhibitor Production, Revenue, Price and Gross Margin (2012-2017)
Table Novartis AG (Switzerland) DPP IV Inhibitor Market Share (2012-2017)
Table Takeda Pharmaceutical Company Limited (Japan) Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Takeda Pharmaceutical Company Limited (Japan) DPP IV Inhibitor Production, Revenue, Price and Gross Margin (2012-2017)
Table Takeda Pharmaceutical Company Limited (Japan) DPP IV Inhibitor Market Share (2012-2017)
Table company 8 Basic Information, Manufacturing Base, Production Area and Its Competitors
Table company 8 DPP IV Inhibitor Production, Revenue, Price and Gross Margin (2012-2017)
Table company 8 DPP IV Inhibitor Market Share (2012-2017)
Table company 9 Basic Information, Manufacturing Base, Production Area and Its Competitors
Table company 9 DPP IV Inhibitor Production, Revenue, Price and Gross Margin (2012-2017)
Table company 9 DPP IV Inhibitor Market Share (2012-2017)
Figure Production Revenue Share of DPP IV Inhibitor by Type (2012-2017)
Figure 2015 Revenue Market Share of DPP IV Inhibitor by Type
Table China DPP IV Inhibitor Price by Type (2012-2017)
Figure China DPP IV Inhibitor Production Growth by Type (2012-2017)
Table China DPP IV Inhibitor Consumption by Application (2012-2017)
Table China DPP IV Inhibitor Consumption Market Share by Application (2012-2017)
Figure China DPP IV Inhibitor Consumption Market Share by Application in 2015
Table China DPP IV Inhibitor Consumption Growth Rate by Application (2012-2017)
Figure China DPP IV Inhibitor Consumption Growth Rate by Application (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of DPP IV Inhibitor
Figure Manufacturing Process Analysis of DPP IV Inhibitor
Figure DPP IV Inhibitor Industrial Chain Analysis
Table Raw Materials Sources of DPP IV Inhibitor Major Manufacturers in 2015
Table Major Buyers of DPP IV Inhibitor
Table Distributors/Traders List
Figure China DPP IV Inhibitor Capacity, Production and Growth Rate Forecast (2017-2021)
Figure China DPP IV Inhibitor Revenue and Growth Rate Forecast (2017-2021)
Table China DPP IV Inhibitor Production, Import, Export and Consumption Forecast (2017-2021)
Table China DPP IV Inhibitor Production Forecast by Type (2017-2021)
Table China DPP IV Inhibitor Consumption Forecast by Application (2017-2021)

COMPANIES MENTIONED

AstraZeneca Plc. (UK)
Boehringer Ingelheim GmbH (Germany)
Eli Lilly and Company (US)
Merck & Co, Inc. (US)
Mitsubishi Tanabe Pharma Corporation (Japan)
Novartis AG (Switzerland)
Takeda Pharmaceutical Company Limited (Japan)